Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Christopher Calabrese.

Newcastle AuthorsTitleYearFull text
Huw Thomas
Dr Christopher Calabrese
Michael Batey
Suzanne Kyle
Professor Herbie Newell
et al.
Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial2007
Huw Thomas
Dr Christopher Calabrese
Professor Herbie Newell
Lan Wang
Professor Nicola Curtin
et al.
Identification of a PARP inhibitor for clinical trial: Preclinical studies2006
Dr Christopher Calabrese
Professor Heinz Grunze
Influence of sub-syndromal symptoms after remission from manic or mixed episodes2006
Dr Christopher Calabrese
Professor Steven Clifford
Dr Richard Gilbertson
The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation2005
Dr Christopher Calabrese
Professor Steven Clifford
Dr Richard Gilbertson
The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation2005
Dr Christopher Calabrese
Michael Batey
Professor Alan Calvert
Professor barbara Durkacz
Suzanne Kyle
et al.
Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG143612004
Dr Christopher Calabrese
Professor Nicola Curtin
Suzanne Kyle
Huw Thomas
Lan Wang
et al.
Design, synthesis, and evaluation of 3,4-dihydro-2H-[1,4]diazepino[6,7,1- hi]indol-1-ones as inhibitors of poly(ADP-ribose) polymerase2004
Dr Christopher Calabrese
Michael Batey
Huw Thomas
Professor barbara Durkacz
Lan Wang
et al.
Identification of potent nontoxic poly(ADP-ribose) polymerase-1 inhibitors: Chemopotentiation and pharmacological studies2003
Dr Christopher Calabrese
Professor Nicola Curtin
Suzanne Kyle
Huw Thomas
Lan Wang
et al.
Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: Design, synthesis, and X-ray cocrystal structure2002
Professor Nicola Curtin
Dr Stephen Barton
Michael Batey
Dr Christopher Calabrese
Professor Alan Calvert
et al.
Anti-cancer chemosensitization in vitro and in vivo by a novel potent poly(ADP-ribose) polymerase (PARP1) inhibitor, TBI-361.2001
Dr Christopher Calabrese
Separation methods for anthraquinone related anti-cancer drugs2001
Dr Christopher Calabrese
Separation methods for anthraquinone related anti-cancer drugs2001
Dr Christopher Calabrese
Professor Nicola Curtin
Michael Batey
Huw Thomas
Suzanne Kyle
et al.
Design and evaluation of novel potent inhibitors of poly (ADP-ribose) polymerase2000
Dr Christopher Calabrese
Huw Thomas
Alex White
Preclinical pharmacology of novel potent inhibitors of PARP1999
Dr Christopher Calabrese
Huw Thomas
Michael Batey
Professor Nicola Curtin
Professor Roger Griffin
et al.
Preclinical pharmacology of novel substituted benzimidazoles - potent inhibitors of poly (ADP-ribose) polymerase1999